{"api":"v1","generated_at":"2026-10-02T17:39:47.448Z","licence":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/","attribution":"TOLL, with a link to the page cited"},"page":"https://tollindex.com/e/api-magentlab-com-api-calc-smm-22020-0c12d6","pinned_page":"https://tollindex.com/e/api-magentlab-com-api-calc-smm-22020-0c12d6/at/2026-10-02T12-31Z","pinned":false,"method":"https://tollindex.com/ledger/method","snapshot_at":"2026-10-02T12:31:46.748Z","snapshot_stamp":"2026-10-02T12-31Z","endpoint":{"slug":"api-magentlab-com-api-calc-smm-22020-0c12d6","canonical_url":"https://api.magentlab.com/api/calc/smm_22020","resource":"https://api.magentlab.com/api/calc/smm_22020","http_method":"POST","type":"http","x402_version":2,"registries":["cdp"],"primary_registry":"cdp","curated_by_coinbase":false,"description":"Lakshman 2018 2/20/20 smoldering myeloma risk: one point each for BMPC >20%, serum M-protein >2 g/dL, and involved/uninvolved FLC ratio >20 (strict greater-than). 0 factors low (median TTP 110 months), 1 intermediate (68), 2 or 3 high (29). Not Mayo 70/20, not PETHEMA, not myeloma ISS, not a treatment order. BMPC 10-59 and FLC 0.01-99.9 (IMWG 2014 SLiM myeloma is rejected). magent does not assay marrow, M-protein, or free light chains.","service_name":"magent","declared_category":null,"declared_tags":["smm-22020","smm","myeloma","hematology","calculator"],"route_template":null,"registry_updated":"2026-09-28T15:13:08.735Z"},"derived":{"note":"fields no registry supplies; TOLL derives them and marks them derived on the page","title":"calc smm 22020","category":"other","first_observed_by_toll":"2026-09-28T13:51:25.436Z","last_observed_by_toll":"2026-10-02T12:31:46.748Z","observation_began":"2026-09-10"},"presence":{"listed_now":true,"first_absent_at":null,"delisting_confirmed_at":null,"events":[{"registry":"cdp","at":"2026-09-28T13:51:25.437Z","event":"listed"}]},"accepts":[{"registry":"cdp","ordinal":0,"network":"eip155:8453","asset":"0x833589fcd6edb6e08f4c7c32d4f71b54bda02913","asset_name":"USD Coin","symbol":"USDC","decimals":6,"amount_display":"0.005 USDC","amount_units":0.005,"decimals_known":true,"pay_to":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"counters":{"observed_at":"2026-10-02T12:31:46.748Z","calls_30d":1,"unique_payers_30d":1,"last_called_at":"2026-09-28T15:13:08.587Z"},"validation":{"latest":{"observed_at":"2026-10-02T13:10:05.666Z","state":"pass","failed_checks":[],"endpoint_http_status":402,"run_id":"daily-2026-10-02"},"uptime":[{"days":7,"observed":6,"passed":6,"ratio":1},{"days":30,"observed":6,"passed":6,"ratio":1},{"days":90,"observed":6,"passed":6,"ratio":1}],"history_90d":[{"observed_at":"2026-10-02T13:10:05.666Z","state":"pass","failed_checks":[],"run_id":"daily-2026-10-02","state_changed":false},{"observed_at":"2026-10-01T06:26:19.858Z","state":"pass","failed_checks":[],"run_id":"daily-2026-10-01","state_changed":false},{"observed_at":"2026-09-30T05:44:15.119Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-30","state_changed":false},{"observed_at":"2026-09-29T18:04:54.097Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-29","state_changed":false},{"observed_at":"2026-09-28T16:52:20.797Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-28","state_changed":false},{"observed_at":"2026-09-28T14:20:32.873Z","state":"pass","failed_checks":[],"run_id":"new-after-daily-2026-09-28","state_changed":true}]},"seller":{"wallet":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","page":"https://tollindex.com/seller/0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","endpoints":844,"hosts":1},"reports":0,"registry_record":{"cdp":[{"tags":["smm-22020","smm","myeloma","hematology","calculator"],"type":"http","accepts":[{"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/smm_22020","assetTransferMethod":"eip3009"},"payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","amount":"5000","scheme":"exact","network":"eip155:8453","maxTimeoutSeconds":600}],"quality":{"lastCalledAt":"2026-09-28T15:13:08.587Z","l30DaysTotalCalls":1,"l30DaysUniquePayers":1},"resource":"https://api.magentlab.com/api/calc/smm_22020","extensions":{"bazaar":{"info":{"input":{"body":{"items":[{"flc_ratio":25,"bmpc_percent":25,"m_protein_g_dl":2.5},{"flc_ratio":25,"bmpc_percent":25,"m_protein_g_dl":2.5}]},"type":"http","method":"POST"},"output":{"type":"json","example":{"path":"/api/calc/smm_22020","count":2,"items":[{"score":3,"formula":"smm_22020","citation":{"id":"lakshman-2018","doi":"10.1038/s41408-018-0077-4","pmid":"29895887","title":"Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria","source":"Blood Cancer J. 2018;8(6):59","authors":"Lakshman A, Rajkumar SV, Buadi FK, et al."},"flc_ratio":25,"max_score":3,"components":[{"value":25,"factor":"bmpc_percent_gt_20","points":1,"present":true},{"value":2.5,"factor":"m_protein_gt_2","points":1,"present":true},{"value":25,"factor":"flc_ratio_gt_20","points":1,"present":true}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","risk_group":"high","bmpc_percent":25,"factor_count":3,"m_protein_g_dl":2.5,"median_ttp_months":29,"formula_expression":"Lakshman 2018 2/20/20 = (bmpc_percent > 20) + (m_protein_g_dl > 2) + (flc_ratio > 20); each 1; max 3; 0 low median TTP 110 months, 1 intermediate 68 months, 2 or 3 high 29 months. Not Mayo 70/20. Not PETHEMA. Not myeloma ISS"},{"score":3,"formula":"smm_22020","citation":{"id":"lakshman-2018","doi":"10.1038/s41408-018-0077-4","pmid":"29895887","title":"Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria","source":"Blood Cancer J. 2018;8(6):59","authors":"Lakshman A, Rajkumar SV, Buadi FK, et al."},"flc_ratio":25,"max_score":3,"components":[{"value":25,"factor":"bmpc_percent_gt_20","points":1,"present":true},{"value":2.5,"factor":"m_protein_gt_2","points":1,"present":true},{"value":25,"factor":"flc_ratio_gt_20","points":1,"present":true}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","risk_group":"high","bmpc_percent":25,"factor_count":3,"m_protein_g_dl":2.5,"median_ttp_months":29,"formula_expression":"Lakshman 2018 2/20/20 = (bmpc_percent > 20) + (m_protein_g_dl > 2) + (flc_ratio > 20); each 1; max 3; 0 low median TTP 110 months, 1 intermediate 68 months, 2 or 3 high 29 months. Not Mayo 70/20. Not PETHEMA. Not myeloma ISS"}]}},"iconUrl":"https://api.magentlab.com/favicon.ico"},"schema":{"type":"object","$schema":"https://json-schema.org/draft/2020-12/schema","required":["input"],"properties":{"input":{"type":"object","required":["type","method"],"properties":{"body":{"type":"object","required":["items"],"properties":{"items":{"type":"array","items":{"type":"object","required":["bmpc_percent","m_protein_g_dl","flc_ratio"],"properties":{"flc_ratio":{"type":"number","description":"Involved/uninvolved serum free light-chain ratio as assigned by the caller (0.01-99.9). >20 scores 1 (Lakshman 2018 2/20/20). 20 scores 0. 100 or above is IMWG 2014 myeloma and is rejected, not scored. magent does not assay free light chains."},"bmpc_percent":{"type":"number","description":"Bone-marrow plasma cells as a percent (10-59). >20 scores 1 (Lakshman 2018 2/20/20). 20 scores 0. 10 is the SMM floor. 60 or above is IMWG 2014 myeloma and is rejected, not scored. magent does not read a marrow."},"m_protein_g_dl":{"type":"number","description":"Serum M-protein in g/dL (0-15). >2 scores 1 (Lakshman 2018 2/20/20). 2 scores 0. magent does not assay M-protein."}}},"maxItems":25,"minItems":1}},"additionalProperties":false},"type":{"type":"string","const":"http"},"method":{"type":"string","const":"POST"},"headers":{"type":"object","additionalProperties":{"type":"string"}}},"additionalProperties":false},"output":{"type":"object","required":["type"],"properties":{"type":{"type":"string"},"example":{"type":"object"}}}}}}},"description":"Lakshman 2018 2/20/20 smoldering myeloma risk: one point each for BMPC >20%, serum M-protein >2 g/dL, and involved/uninvolved FLC ratio >20 (strict greater-than). 0 factors low (median TTP 110 months), 1 intermediate (68), 2 or 3 high (29). Not Mayo 70/20, not PETHEMA, not myeloma ISS, not a treatment order. BMPC 10-59 and FLC 0.01-99.9 (IMWG 2014 SLiM myeloma is rejected). magent does not assay marrow, M-protein, or free light chains.","lastUpdated":"2026-09-28T15:13:08.735Z","serviceName":"magent","x402Version":2}]}}